Research Article

Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish

Volume: 13 Number: 2 September 18, 2023
EN

Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish

Abstract

Objective: Porphyromonas gingivalis (P. gingivalis), a major periodontopathogen, is associated with overfeeding disorders, including metabolic syndrome. Gingipains are one of the most powerful endotoxins of P. gingivalis. Our aim was to reveal the effects of gingipain injections on the intestinal oxidant-antioxidant status and alkaline phosphatase (ALP) activity in overfed zebrafish. Materials and Methods: Four groups of healthy adult zebrafish were placed in random tanks as C: Control (n=15); GP: Gingipain (n=15); OF: Overfeeding (n=15); and OF+GP: Overfeeding+Gingipain (n=15) groups. At the end of the experiment, levels of intestinal lipid peroxidation (LPO) and ALP, glutathione S-transferase (GST), and catalase (CAT) activities were evaluated. Results: Intestinal LPO was significantly lower in the GP and OF groups compared to C. Gingipain injection in OF (OF+GP) significantly elevated LPO when compared to C, GP, and OF groups. ALP activities decreased significantly in the GP, OF, and OF+GP compared to C. GST activities increased significantly in the GP when compared to C. Decreased GST activities were observed in the OF and OF+GP. This decrease was less in OF+GP. CAT activities significantly decreased in all groups when compared to C. Conclusion: Our findings demonstrate that gingipain injection alters the ALP activity and intestinal oxidant-antioxidant status in overfed zebrafish.

Keywords

Supporting Institution

Marmara University Scientific Research and Project Commission

Project Number

Project No: TDK-2021-10420.

References

  1. 1. Mysak J, Podzimek S, Sommerova P, Lyuya-Mi Y, Bartova J, Janatova T, et al. Porphyromonas gingivalis: Major periodontopathic pathogen overview. J Immunol Res 2014; 2014: 476068. google scholar
  2. 2. Xu W, Zhou W, Wang H, Liang S. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis. Adv Protein Chem Struct Biol 2020; 120: 45-84. google scholar
  3. 3. Nunes JM, Fillis T, Page MJ, Venter C, Lancry O, Kell DB, et al. Gingipain R1 and lipopolysaccharide from Porphyromonas gingivalis have major effects on blood clot morphology and mechanics. Front Immunol 2020; 11: 1551. google scholar
  4. 4. Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 2019; 5(1): eaau3333. google scholar
  5. 5. Tsuzuno T, Takahashi N, Yamada-Hara M, Yokoji-Takeuchi M, Sulijaya B, Aoki-Nonaka Y, et al. Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice. J Periodontal Res 2021; 56(2): 275-88. google scholar
  6. 6. Mei F, Xie M, Huang X, Long Y, Lu X, Wang X, et al. Porphyromonas gingivalis and its systemic impact: Current status. Pathogens 2020; 9(11): 944. google scholar
  7. 7. Bullon P, Morillo J, Ramirez-Tortosa MC, Quiles J, Newman H, Battino M. Metabolic syndrome and periodontitis: Is oxidative stress a common link? J Dent Res 2009; 88(6): 503-18. google scholar
  8. 8. Nibali L, Tatarakis N, Needleman I, Tu Y-K, D’Aiuto F, Rizzo M, et al. Association between metabolic syndrome and periodontitis: A systematic review and meta-analysis. J Clin Endocrinol Metab 2013; 98(3): 913-20. google scholar

Details

Primary Language

English

Subjects

Clinical Sciences (Other)

Journal Section

Research Article

Publication Date

September 18, 2023

Submission Date

March 24, 2023

Acceptance Date

May 5, 2023

Published in Issue

Year 2023 Volume: 13 Number: 2

APA
Gündüz, G., Beler, M., Ünal, İ., Cansız, D., Emekli Alturfan, E., & Kose, K. N. (2023). Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish. Experimed, 13(2), 80-85. https://doi.org/10.26650/experimed.1268503
AMA
1.Gündüz G, Beler M, Ünal İ, Cansız D, Emekli Alturfan E, Kose KN. Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish. Experimed. 2023;13(2):80-85. doi:10.26650/experimed.1268503
Chicago
Gündüz, Gizem, Merih Beler, İsmail Ünal, Derya Cansız, Ebru Emekli Alturfan, and Kemal Naci Kose. 2023. “Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish”. Experimed 13 (2): 80-85. https://doi.org/10.26650/experimed.1268503.
EndNote
Gündüz G, Beler M, Ünal İ, Cansız D, Emekli Alturfan E, Kose KN (September 1, 2023) Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish. Experimed 13 2 80–85.
IEEE
[1]G. Gündüz, M. Beler, İ. Ünal, D. Cansız, E. Emekli Alturfan, and K. N. Kose, “Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish”, Experimed, vol. 13, no. 2, pp. 80–85, Sept. 2023, doi: 10.26650/experimed.1268503.
ISNAD
Gündüz, Gizem - Beler, Merih - Ünal, İsmail - Cansız, Derya - Emekli Alturfan, Ebru - Kose, Kemal Naci. “Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish”. Experimed 13/2 (September 1, 2023): 80-85. https://doi.org/10.26650/experimed.1268503.
JAMA
1.Gündüz G, Beler M, Ünal İ, Cansız D, Emekli Alturfan E, Kose KN. Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish. Experimed. 2023;13:80–85.
MLA
Gündüz, Gizem, et al. “Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish”. Experimed, vol. 13, no. 2, Sept. 2023, pp. 80-85, doi:10.26650/experimed.1268503.
Vancouver
1.Gizem Gündüz, Merih Beler, İsmail Ünal, Derya Cansız, Ebru Emekli Alturfan, Kemal Naci Kose. Gingipain Injection Affects Intestinal OxidantAntioxidant Status and Alkaline Phosphatase in Overfed Zebrafish. Experimed. 2023 Sep. 1;13(2):80-5. doi:10.26650/experimed.1268503